ESR1 and breast neoplasm: We recently showed that SOX2 was expressed at higher levels in estrogen receptor-positive (ER+) breast tumor tissue samples from The Cancer Genome Atlas (TCGA) data set and also in tamoxifen-resistant MCF-7 breast cancer sub-lines (19).